Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge

Abroad (travel likely)Recruiting

Conditions

Immune-Related Adverse Events

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China
Contact: Study coordinator (binhe Tian) · 17782646786@163.com · 17782646786

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients

Immune-Related Adverse Events · Lupus Erythematosus, Systemic · Sjogren Syndrome

Abroad (travel likely)Recruiting

Pamplona, Spain

Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis

Pneumonitis · Immune-related Adverse Event

Abroad (travel likely)RecruitingPHASE2

Calgary, Canada

Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Inflammatory Arthritis · Immune-related Adverse Event

Abroad (travel likely)RecruitingPHASE2

London, Canada

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

Pathological Complete Remission · Objective Response Rate · Immune-related Adverse Events

Abroad (travel likely)Recruiting

Jinan, China